Calls & tenders
Join us today
Open call for free vaccine development services: apply now!
Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills and technical capacities not readily available at a single organization.
EVI-led project, TRANSVAC2, is now also offering services as part of ISIDORe, Integrated Services for Infectious Disease Outbreak Research, to support scientists and their research on epidemic- and pandemic-prone pathogens.
Are you a researcher in academia, SME or industry looking for support for vaccine development project? Check out the services available and apply now!
There are currently 5 open calls:
Risk 4 pathogens
Vector-borne pathogens & their vectors
Other pathogens with epidemic potential
The ISIDORe project assembles the largest and most diverse research and service-providing instrument to study infectious diseases in Europe, with expertise from structural biology to clinical trials.
ISIDORe brings together under the same umbrella 17 major European life sciences research infrastructures and infectious diseases networks, including EVI-led TRANSVAC, to accelerate the generation of new knowledge and intervention tools to enhance Europe’s capacity for controlling (re)emerging and epidemic infectious diseases.
TRANSVAC2 is a European vaccine research and development (R&D) infrastructure project coordinated by the European Vaccine Initiative (EVI) and dedicated to accelerating the development of safe, effective and affordable vaccines. TRANSVAC2 has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement N° 730964.
ISIDORe gives scientists access to the whole extent of our state-of-the-art facilities, cutting-edge services, advanced equipment and expertise, in an integrated way and with a common goal, to accelerate the generation of new knowledge and intervention tools to enhance Europe’s capacity for controlling (re)emerging and epidemic infectious diseases.
ISIDORe has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement number 101046133.
There are no tenders for the moment. Stay tuned.